The first case of treatment of drug-induced agranulocytosis with recombinant GM-CSF was reported by Palmblad J et al. in 1990.11 Various cases have been reported later where drug-induced agranulocytosis was treated with G-CSF. This evidence concerns the gene CSF2 and Absence of circulating granulocytes.